Prenosis is a Chicago-based company that specializes in providing advanced decision support tools for physicians to improve patient care and outcomes. Their proprietary platform, Immunix, utilizes machine learning algorithms to analyze a patient's individual immune profile and predict future outcomes based on a comprehensive database of historical patient data and outcomes. By synthesizing biological data with clinical parameters, Prenosis aims to prioritize patients, deliver the right therapy faster, and reduce hospital costs.
With a team of experienced professionals, including CEO and co-founder Bobby Reddy, Jr., Ph.D., who has extensive expertise in early screening technologies for debilitating diseases, Prenosis is dedicated to decoding the atypical human immune response. Their passion for improving patient care is evident in their commitment to providing physicians with real-time information and evidence-based precision medicine, ultimately saving lives and money.
Generated from the website